Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia: genes and variants
Explore variant evidence for Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia across 1 analyzed protein (ACVRL1). Linked ClinVar records include 6 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 0 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia
ACVRL1: Activin receptor type-1-like
It mediates BMP9 and BMP10 signaling in vascular endothelial cells and helps maintain normal vessel maturation and quiescence. Heterozygous loss-of-function variants cause hereditary hemorrhagic telangiectasia type 2, with telangiectasias and arteriovenous malformations.
6 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in ACVRL1 have source records linked to Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| ACVRL1 V198E | 198 | GS | Pathogenic / likely pathogenic |
| ACVRL1 Q201R | 201 | GS | Pathogenic / likely pathogenic |
| ACVRL1 R218P | 218 | Protein kinase | Pathogenic / likely pathogenic |
| ACVRL1 D263G | 263 | Protein kinase | Pathogenic / likely pathogenic |
| ACVRL1 W399L | 399 | Protein kinase | Pathogenic / likely pathogenic |
| ACVRL1 D427V | 427 | Protein kinase | Pathogenic / likely pathogenic |
Same protein, different disease
- Hereditary hemorrhagic telangiectasia also has ClinVar records linked to ACVRL1 variants; they fall mostly in different places as the Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia variants (180 pathogenic / likely pathogenic).
- Primary pulmonary hypertension also has ClinVar records linked to ACVRL1 variants; they fall mostly in different places as the Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia variants (3 pathogenic / likely pathogenic).
Diseases related to Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia
- Hemophilia A, also linked to ACVRL1
- Hereditary hemorrhagic telangiectasia, also linked to ACVRL1
- Primary pulmonary hypertension, also linked to ACVRL1
- Pulmonary arterial hypertension, also linked to ACVRL1
Frequently asked questions
Which genes have records linked to Pulmonary arterial hypertension related to hereditary hemorrhagic telangiectasia?
This view contains 1 analyzed proteins: ACVRL1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 6 pathogenic or likely pathogenic variants, 0 variants of uncertain significance and 0 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 6 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center